Balyasny Asset Management

Balyasny Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Balyasny Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$7.24M	Buy
2019 Q2	–	Sell
2019 Q1	$1.46M	Buy
2018 Q4	$259K	Buy
2018 Q2	–	Sell
2018 Q1	$690K	Sell
2017 Q4	$6.95M	Buy
2017 Q3	$268K	Buy